Amivantamab (JNJ-61186372)-induced adverse cutaneous reaction

Indian J Dermatol Venereol Leprol. 2023;90(1):108-110. doi: 10.25259/IJDVL_717_2022.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Antibodies, Bispecific*
  • Humans
  • Skin

Substances

  • amivantamab-vmjw
  • Antibodies, Bispecific